Get the Stockscreener App
1.38
3.50%
-0.05
Neuronetics Inc stock is traded at $1.38, with a volume of 1.48M.
It is down -3.50% in the last 24 hours and down -27.37% over the past month.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
See More
Previous Close:
$1.43
Open:
$1.42
24h Volume:
1.48M
Relative Volume:
0.75
Market Cap:
$94.51M
Revenue:
$69.23M
Net Income/Loss:
$-33.10M
P/E Ratio:
-1.1695
EPS:
-1.18
Net Cash Flow:
$-39.26M
1W Performance:
-23.33%
1M Performance:
-27.37%
6M Performance:
-61.02%
1Y Performance:
-72.40%
1-Day Range:
$1.33
$1.48
1-Week Range:
$1.33
$1.8192
52-Week Range:
$1.25
$5.92
Neuronetics Inc Stock (STIM) Company Profile
Name
Neuronetics Inc
Sector
Industry
Phone
877-600-7555
Address
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.38 | 97.93M | 69.23M | -33.10M | -39.26M | -1.18 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-13-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-22-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jul-24-18 | Initiated | Canaccord Genuity | Buy |
View All
Neuronetics Inc Stock (STIM) Latest News
Neuronetics CEO Sullivan sells $55,847 in shares - Investing.com UK
Malvern-Based Neuronetics Reports Preliminary 2025 Revenue Growth and Positive Cash Flow - MyChesCo
Neuronetics Revises Financial Results for Q4 and Full Year 2024 - MSN
What’s the RSI of Neuronetics Inc. stockShare Buyback & Real-Time Volume Surge Alerts - mfd.ru
Neuronetics (STIM) Is Down 9.0% After Turning Cash-Flow Positive On NeuroStar Demand Has The Bull Case Changed? - Sahm
Assessing Neuronetics (STIM) Valuation After Positive Cash Flow And Strong Preliminary Q4 Revenue - Yahoo Finance
How cyclical is Neuronetics Inc.’s revenue streamJuly 2025 Decliners & AI Driven Price Forecasts - mfd.ru
Can Neuronetics Inc. outperform in the next rallyOptions Play & AI Powered Trade Plan Recommendations - mfd.ru
Keith Sullivan Sells 40,976 Shares of Neuronetics (NASDAQ:STIM) Stock - MarketBeat
Neuronetics Beats Expectations with Strong Q4 Revenue and Cash Flow - timothysykes.com
Neuronetics Expects Q4 Revenue To Increase 86%; Stock Up - Nasdaq
Neuronetics reports 86% revenue growth in Q4 2025 By Investing.com - Investing.com South Africa
STIM Stock Price, Forecast & Analysis | NEURONETICS INC (NASDAQ:STIM) - ChartMill
Neuronetics (STIM) Stock Rises 41% After Hours: What's Going On? - Benzinga
STIM Closes 2025 with Strong Cash Position of $34.1 Million - GuruFocus
Neuronetics (STIM) Reports Positive Cash Flow Amid Strong Demand - GuruFocus
Neuronetics Reports Preliminary Fiscal Q4, 2025 Results - marketscreener.com
Neuronetics reports 86% revenue growth in Q4 2025 - Investing.com
Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Neuronetics, Inc. Reports Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025, Highlighting Significant Revenue Growth - Quiver Quantitative
Neuronetics lifts 2025 revenue 99%, books positive Q4 operating cash flow - Stock Titan
Market Review: Why is Neuronetics Inc stock going upMarket Performance Recap & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Selling Neuronetics Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - 富途牛牛
Trade Report: Is Neuronetics Inc stock a buy or sellJuly 2025 Closing Moves & Technical Buy Zone Confirmations - baoquankhu1.vn
Sentiment Watch: Whats the profit margin of Neuronetics IncQuarterly Portfolio Report & Weekly Breakout Watchlists - baoquankhu1.vn
Aug Movers: Is Neuronetics Inc trading at a discount2025 Macro Impact & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Signal Recap: Is RBLX a momentum stockJuly 2025 Sentiment & Expert Approved Trade Ideas - baoquankhu1.vn
Neuronetics, Inc. (STIM) Stock Analysis: A Promising 206% Upside In The Healthcare Sector - DirectorsTalk Interviews
Following a 26% decline over last year, recent gains may please Neuronetics, Inc. (NASDAQ:STIM) institutional owners - simplywall.st
Neuronetics Sees Unusually Large Options Volume (NASDAQ:STIM) - MarketBeat
Neuronetics amends credit agreement, adjusts subsidiary guarantee terms - TipRanks
Death Cross: Can Beazer Homes USA Inc stock double in the next yearQuarterly Market Review & Stock Portfolio Risk Management - baoquankhu1.vn
Neuronetics CFO Stephen Furlong sells shares worth $48,662 - MSN
Gains Report: Will GCM Grosvenor Inc Equity Warrant outperform small cap indexesWeekly Trade Recap & Community Driven Trade Alerts - baoquankhu1.vn
Neuronetics (STIM) Just Went Wild: Is This Brain-Tech Underdog Your Next Moonshot or Total Trap? - AD HOC NEWS
Aug Patterns: Will SLRX benefit from government policyM&A Rumor & Fast Gain Stock Tips - baoquankhu1.vn
Analysis Recap: Can Neuronetics Inc maintain sales growthPortfolio Performance Report & Momentum Based Trading Signals - baoquankhu1.vn
Aug Rallies: Does Neuronetics Inc have pricing powerDollar Strength & High Accuracy Trade Alerts - baoquankhu1.vn
Analyst Downgrade: Why Neuronetics Inc stock is seen as undervalued2025 Key Lessons & Real-Time Volume Spike Alerts - Bộ Nội Vụ
Winners Losers: Will Neuronetics Inc stock continue upward momentumWeekly Investment Report & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
Neuronetics (NASDAQ:STIM) Stock Price Down 4.3%Here's What Happened - MarketBeat
Neuronetics Announces Stock Awards to New Employees - MSN
Why Neuronetics Inc. stock is considered a top pickTrade Exit Summary & Smart Investment Allocation Tips - Улправда
Can Neuronetics Inc. stock deliver sustainable ROETrade Analysis Report & Expert Curated Trade Setups - Улправда
Will Neuronetics Inc. stock return to pre crisis levels2025 Historical Comparison & Precise Entry and Exit Recommendations - ulpravda.ru
Neuronetics Grants Retention-Focused Incentive Awards to Executives - TipRanks
Published on: 2026-01-09 06:58:05 - Улправда
Neuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent Depression - MSN
How Neuronetics Inc. stock reacts to oil pricesEarnings Miss & Technical Analysis for Trade Confirmation - Улправда
Why hedge funds are buying Neuronetics Inc. stockTrade Analysis Report & Daily Oversold Stock Bounce Ideas - Улправда
Ideas Watch: Is Neuronetics Inc stock a contrarian buyAnalyst Upgrade & High Accuracy Trade Alerts - moha.gov.vn
Neuronetics Inc Stock (STIM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):